Quantcast
Last updated on April 24, 2014 at 5:50 EDT

Latest Platelet Stories

2012-07-18 06:27:35

NEW YORK, July 18, 2012 /PRNewswire/ -- Cytomedix, Inc. (OTC/BB: CMXI), a regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies for wound and tissue repair, announced that their July 12th RetailInvestorConferences.com presentation is now available for on-demand viewing. LINK: www.retailinvestorconferences.com > red "register/ watch event now" button Cytomedix, Inc.'s presentation will be available 24/7 for 90...

2012-07-17 23:00:15

Cytomedix selects award-winning healthcare communications agency bryantBROWN to promote the Angel Whole Blood Separation System. Contact bryantBROWN at http://www.bryantbrown.com for more information. Los Angeles, CA (PRWEB) July 17, 2012 Award-winning healthcare communications agency bryantBROWN Healthcare has created the promotional campaign for the Angel Whole Blood Separation System for Cytomedix. Angel is an advanced blood processing device and disposable products used for the...

2012-07-10 10:25:57

NEW YORK, July 10, 2012 /PRNewswire/ -- Cytomedix, Inc. (OTC: CMXI), a regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies for wound and tissue repair, announced that Martin P. Rosendale, Chief Executive Officer, will present at RetailInvestorConferences.com. DATE: July 12, 2012 TIME: 11:00 AM EDT LINK: www.retailinvestorconferences.com > red "register / watch event now" button This will be a live, interactive...

2012-07-05 10:22:42

Eltrombopag, a drug that was designed to stimulate production of platelets from the bone marrow and thereby improve blood clotting, can raise blood cell levels in some people with severe aplastic anemia who have failed all standard therapies. About one-third of aplastic anemia cases do not respond to standard therapy, a combination of immune-suppressing drugs. Although bone marrow stem cell transplantation is an option for some, patients without a matched donor have few treatment options....

2012-06-28 06:26:00

WASHINGTON, June 28, 2012 /PRNewswire/ -- Greg Biffle, driver of the No. 16 Red Cross Ford Fusion, is supporting the American Red Cross in its emergency call for blood and platelet donors. (Photo: http://photos.prnewswire.com/prnh/20120628/CG32654-INFO) Biffle is encouraging fans in small towns across the country to raise awareness about the need for lifesaving blood donations this summer. Small towns are big supporters of the blood supply, with almost 38 percent of Red Cross blood drives...

2012-06-25 02:25:51

Blood and platelet donors of all types needed WASHINGTON, June 25, 2012 /PRNewswire-USNewswire/ -- The American Red Cross is calling on all eligible donors to step up, roll up a sleeve and give blood or platelets as soon as possible. (Logo: http://photos.prnewswire.com/prnh/20090108/RedCrossLOGO) The Red Cross says its blood supply has reached emergency levels, with 50,000 fewer donations than expected in June. This shortfall leaves about half the readily available blood...

2012-06-24 23:00:02

U.S.A. Hurdle specialist Kellie Wells has joined elite athletes Tiger Woods, Hines Ward and Takaishi Saito in using Cell Therapy. According to A.J. Farshchian, MD, an Orthopedic Regenerative practitioner at The Center for Regenerative Medicine, "Sport injuries need an adequate blood supply and cellular migration. Platelet-derived growth factors are critically involved in this process." Miami, FL (PRWEB) June 24, 2012 U.S.A. Hurdle specialist Kellie Wells has joined elite athletes Tiger...

2012-06-22 10:23:29

LYNDHURST, N.J., June 22, 2012 /PRNewswire/ -- From 2012 Olympiads, to professional athletes, to weekend warriors, Platelet-Rich Plasma (PRP) therapy is a hot new remedy for sports injuries and chronic pain conditions. Experts in Interventional Pain Medicine, the New Jersey (NJ) pain management doctors at Metropolitan Pain Consultants integrate PRP injections with other multi-modal pain relief strategies including nerve blocks, spinal injections, spinal cord stimulators, facet joint...

2012-06-15 06:23:57

LONDON, June 15, 2012 /PRNewswire/ -- Demand for universal blood type O Negative expected to be higher than donations being made during the games New statistics from NHS Blood and Transplant (NHSBT) announced yesterday reveal a gap between demand and supply of blood type O Rh Negative (O Negative) during national celebrations and underline an urgent need for O Negative donors to come forward ahead of the Olympics next month....

2012-06-14 06:24:03

AMARILLO, Texas, June 14, 2012 /PRNewswire/ -- CytoPharm, Inc. and Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced positive clinical findings from a dose-ranging, Phase 2 clinical trial of patients infected with hepatitis C virus (HCV) in Taiwan. A total of 169 HCV patients (genotype 1b) were randomized to receive oral lozenges containing 500 or 1500 international units (IU) of natural human interferon-alpha (IFNa) or matching placebo for 24 weeks, followed by 24 weeks of untreated...